Home » In the News » The 2024 National Health Research Forum, a two-day, free event covering today’s top research topics

The 2024 National Health Research Forum, a two-day, free event covering today’s top research topics

WHAT:

The 2024 National Health Research Forum on Sept. 17 and 18. With our supporters, Research!America hosts meaningful conversations aimed at capturing the power of research and development to revolutionize health and health care, exploring new and potentially overlooked opportunities and challenges, and confronting current and looming health threats.

The issues and challenges addressed at the Forum are curated by our expert staff, who bring decades of policy, government, and advocacy experience to the process. Discussions will explore issues at the intersection of public policy and medical and scientific progress.

Join us for discussions with top federal officials, research leaders, and media on timely topics such as climate change’s impact on health, clinical trials, artificial intelligence (AI) and drug development, nutrition and health, and navigating comorbidities in mental health.

WHO:

  • Sethuraman Panchanathan, PhD, Director of the National Science Foundation (NSF)
  • Dr. Laurie Locascio, PhD, Under Secretary of Commerce for Standards and Technology and Director of the National Institute of Standards and Technology (NIST)
  • Dr. Monica Bertagnolli, MD, Director of the National Institutes of Health (NIH)
  • Dr. Mandy Cohen, MD, MPH, Director of the Centers for Disease Control and Prevention (CDC)
  • Dr. Robert Valdez, PhD, MHSA, Director of the Agency for Healthcare Research and Quality (AHRQ)
  • Dawn O’Connell, JD, Assistant Secretary for Preparedness and Response (ASPR), HHS
  • Dr. Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration
  • Dr. Nakela Cook, MD, MPH, Executive Director of the Patient-Centered Outcomes Research Institute (PCORI)
  • Matthew Hall, PhD, Scientific Director of the National Center for Advancing Translational Sciences (NCATS)
  • Meghana Chalasani, Associate Director, Clinical Trial Innovation, FDA’s Center for Drug Evaluation and Research (CDER)
  • Sudip Parikh, PhD, CEO of AAAS
  • Mary Woolley, CEO and President Research!America
  • Julie Gerberding, MD, MPH, CEO of the Foundation for the National Institutes of Health
  • Katie Robertson, PhD, Roche Diagnostics’ Disease Area Network Lead for Oncology, Medical and Scientific Affairs
  • Josh Gordon, MD, PhD, Past Director, NIMH, Columbia University
  • Arthur Evans, PhD, CEO & EVP, American Psychological Association
  • Plus, many more!

WHEN AND WHERE:

The Sept. 17 sessions will be virtual, while the Sept. 18 discussions will be in person on the campus of the George Washington University (GWU), followed by a reception at GWU. It’s free but registration is required, register here for the virtual day, and register here for the in-person day.

Home